Axela Biosensors Inc. to Develop Commercial Biomarker Assays With BioCheck’s Antibody Reagents

TORONTO, May 7 /PRNewswire/ -- Axela Biosensors, Inc. and BioCheck, Inc. today announced a licensing and supply agreement for clinical reagents that will be commercialized into biomarker assays on Axela's dotLab(TM) System.